The use of zoledronic acid in Japanese men with stage D2 prostate cancer

Zoledronic acid (ZOL) is a new generation bisphosphonate with improved efficacy benefits over pamidronate in preclinical testing. In addition, ZOL is superior to pamidronate in the treatment of hypercalcemia of malignancy. ZOL is also the first bisphosphonate to demonstrate efficacy in patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: NAKAMURA, KOGENTA, YAMADA, YOSHIAKI, ROSSER, CHARLES J., ARAKAWA, MAKI, ZENNMAI, KENJI, KATO, YOSHIHARU, WATANABE, MASAHITO, KATSUDA, REMI, TOBIUME, MOTOI, NARUSE, KATSUYA, AOKI, SHIGEYUKI, TAKI, TOMOHIRO, SAITO, HIROKO, HASEGAWA, TAKAAKI, HONDA, NOBUAKI
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2010
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3436424/
https://ncbi.nlm.nih.gov/pubmed/22966248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol_00000002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados